Clinical Trials Logo

Clinical Trial Summary

Split-thickness skin graft (STSG) is one of the most common procedures performed in plastic surgery and dermatology. The donor site of skin grafting is expected to heal without scarring. However, hypertrophic scar formation is prevalent among STSG donor sites during scar maturation and has become a significant problem at present. Hypertrophic scar results in aesthetic, physical, functional, and psychological problems, leading to a dramatic impact on patients' quality of life ultimately. There are many current therapeutic approaches for preventing and treating hypertrophic scars; however, they remain clinically unsatisfactory because many treatments have been associated with high recurrent rates, high cost, and side effects. Currently, there are no gold standards for hypertrophic scar therapy. There are many attempts to develop new treatment options for the prevention and management of scarring that are acceptable to both physicians and patients. It has previously been shown that both edible bird's nest (EBN) extract and sericin have effectiveness in reducing scar development. They might be a suitable alternative option for scar prevention and could be used safely. Therefore, the sericin hydrogel sheet impregnated with EBN extract is developed as it is believed that the synergism of these combined compounds would be a great help to prevent the development of scars. This study aims to evaluate the efficacy and safety of sericin hydrogel sheet impregnated with EBN extract for the prevention of scar formation in patients with STSG donor sites.


Clinical Trial Description

Prospective, randomized, single-center, double-blinded, placebo-controlled, matched pairs clinical study will be conducted to investigate the efficacy and safety of sericin hydrogel sheet impregnated with EBN extract for the prevention of scar development at STSG donor site. Patients who underwent the STSG procedure at the Division of Plastic and Reconstructive Surgery, Department of Surgery, King Chulalongkorn Memorial Hospital will be considered for inclusion and exclusion criteria. Thirty patients will be enrolled in this study. After complete epithelialization, each donor site will be equally divided into two halves: upper and lower halves. Both halves of the donor site will be randomized into sericin hydrogel sheet impregnated with EBN extract group (treatment group) or placebo hydrogel sheet group (control group). The application of both dressings will be done once daily by the patient in the morning or evening after shower. Both dressings will be recommended to wear over the donor site for 8-12 hours per day. The duration of treatment will be six months. Wound quality at 1, 2, 4, and 6 months after starting application will be measured in terms of erythema level, melanin level, transepidermal water loss by using Cutometer® and scar quality (Vancouver scar scale as well as Patient and Observer Scar Assessment Scale). Adverse reactions will also be evaluated. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04997863
Study type Interventional
Source Chulalongkorn University
Contact Pornanong Aramwit, Ph.D
Phone +66899217255
Email aramwit@gmail.com
Status Not yet recruiting
Phase N/A
Start date November 1, 2021
Completion date October 31, 2022

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03649308 - Negative Pressure Wound Therapy Compared to Traditional Care After Skin Grafting N/A
Recruiting NCT03674749 - The Effects of Meditation and Hyperbaric Oxygen Therapy on Chronic Wounds N/A
Completed NCT06464250 - The Effect of Bundle Approach on Foot Care Behaviors and Diabetic Wound Healing in Patients N/A
Withdrawn NCT03909503 - A Case Series Evaluating a Collagen Wound Dressing to Treat Wounds N/A
Completed NCT05297721 - Nurses' Level of Knowledge on Skin Tears: A Cross-Sectional Study
Recruiting NCT03386175 - Efficiency of Negative Pression Therapy With Instillation in the Debridement of Wound
Active, not recruiting NCT04701632 - Prevalence and Variables Associated With Depression in Subjects With Chronic Wounds Using PHQ-9 as a Screening Tool
Completed NCT05618496 - Multi-centre, Open-label, First-in-man Study With Epipad Used in Adult Patients N/A
Not yet recruiting NCT03640871 - HEAL Study: Healing Results, Efficacy and Acceptability of a New Contact Layer N/A
Completed NCT02399722 - Combination of a Polymeric Membrane Dressing Plus Negative Pressure Wound Therapy Against Negative Pressure Wound Therapy Alone N/A
Completed NCT04507724 - The Use of Biochemical Analyzes to Monitor the Development of Wounds
Recruiting NCT05556954 - Diabetic Foot Ulcers Microbiome and Pathogen Identification
Completed NCT03938584 - The Effect of Vitamin C on Wound Healing In Mandibular Fracture Patients N/A
Terminated NCT03723603 - An Evaluation of a Collagen Dressing to Treat Chronic, Stalled Lower-extremity Wounds N/A
Completed NCT03754426 - A Prospective, Pilot Evaluation of Device Equivalence
Recruiting NCT02643680 - Clinical Study of Biocellulose Wound Dressing Containing Silk Sericin and PHMB for STSG Donor Sites Phase 2
Recruiting NCT01913132 - PICO Above Incisions After Vascular Surgery N/A
Recruiting NCT01347489 - Cronic Pressure Wounds and Relation With Gender N/A
Recruiting NCT04621825 - Post Market Surveillance Study to Confirm Safety and Performance of Silicone PHMB Foam N/A
Withdrawn NCT03723577 - An Evaluation of a Fibrillar Collagen Dressing to Treat Chronic, Stalled Lower-extremity Wounds N/A